During the past decade, LMC Etobicoke conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "LMC Etobicoke" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott Diabetes Care" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "LMC Etobicoke" are "Diabetes Mellitus, Type 2" (4 trials), "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus" (1 trials), "Glucose" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "LMC Etobicoke" in a lesser frequency.

Most popular intervention types in "LMC Etobicoke" are "Drug" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Basal insulin Basaglar/Lantus + gliclazide MR" (1 trials), "Basal insulin glargine and lixisenatide" (1 trials), "Colesevelam" (1 trials) and "Diabetes self-management education" (1 trials). Other intervention names were less common.

The vast majority of trials in "LMC Etobicoke" are 7 trials for "All" genders.

Currently, there are NaN active trials in "LMC Etobicoke". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in LMC Etobicoke, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LMC Etobicoke, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".